Negative equity of -$1.7M against $38.6M of total liabilities and a current ratio of 0.14 indicates that the capital structure is highly leveraged and liquidity is thin relative to obligations.
DataMEDS AI, Inc. (MEDS) balance sheet — 3-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 |
|---|
| Total Current Assets | 5.22M | 2.82M | 15.17M | 338.36K |
| Cash & Short-Term Investments | 476.6K | 42.57K | 1.03M | 1.36K |
| Cash Only | 476.6K | 42.57K | 1.03M | 1.36K |
| Short-Term Investments | 0 | 0 | 0 | 0 |
| Accounts Receivable | 3.13M | 1.14M | 3.75M | 337K |
| Days Sales Outstanding | 76.75 | 17.79 | 75.42 | - |
| Inventory | 1.44M | 1.64M | 9.52M | 0 |
| Days Inventory Outstanding | 32.18 | 18.15 | 212.35 | - |
| Other Current Assets | 0 | 0 | 875.39K | 0 |
| Total Non-Current Assets | 33.51M | 27.64M | 42.16M | 0 |
| Property, Plant & Equipment | 1.91M | 1.2M | 1.92M | 0 |
| Fixed Asset Turnover | 6.08x | 19.51x | 9.46x | - |
| Goodwill | 15.79M | 14.19M | 16.22M | 0 |
| Intangible Assets | 13.25M | 10.31M | 22.36M | 0 |
| Long-Term Investments | 35K | 0 | 17.67K | 0 |
| Other Non-Current Assets | 2.53M | 1.94M | 1.65M | 0 |
| Total Assets | 38.73M | 30.46M | 57.33M | 338.36K |
| Asset Turnover | 0.23x | 0.77x | 0.32x | - |
| Asset Growth % | -161.18% | -46.87% | 16844.08% | - |
| Total Current Liabilities | 37.91M | 29.78M | 38.05M | 2.89M |
| Accounts Payable | 13.06M | 11.69M | 6.33M | 1.04M |
| Days Payables Outstanding | 252.06 | 129.4 | 141.31 | - |
| Short-Term Debt | 18.06M | 11.07M | 12.04M | 350K |
| Deferred Revenue (Current) | 514.23K | 488.23K | 245.76K | 0 |
| Other Current Liabilities | 5.53M | 4.59M | 3.11M | 950K |
| Current Ratio | 0.14x | 0.09x | 0.40x | 0.12x |
| Quick Ratio | 0.10x | 0.04x | 0.15x | 0.12x |
| Cash Conversion Cycle | -143.13 | -93.47 | 146.46 | - |
| Total Non-Current Liabilities | 648.72K | 13.13M | 12.55M | 350K |
| Long-Term Debt | 100K | 13.13M | 11.46M | 350K |
| Capital Lease Obligations | 548.72K | 0 | 1.1M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Total Liabilities | 38.56M | 42.91M | 50.6M | 3.24M |
| Total Debt | 19.94M | 24.77M | 25.11M | 700K |
| Net Debt | 19.47M | 24.73M | 24.08M | 698.64K |
| Debt / Equity | 116.15x | - | 3.73x | - |
| Debt / EBITDA | -0.72x | - | - | - |
| Net Debt / EBITDA | -0.70x | - | - | - |
| Interest Coverage | -4.32x | -21.11x | -7.25x | -191.01x |
| Total Equity | 171.69K | -12.45M | 6.73M | -2.9M |
| Equity Growth % | -3073.17% | -284.84% | 332.19% | - |
| Book Value per Share | 0.04 | -8.77 | 6.48 | -3.24 |
| Total Shareholders' Equity | -1.7M | -12.45M | 6.73M | -2.9M |
| Common Stock | 473 | 10.13K | 5.11K | 4.47K |
| Retained Earnings | -126.55M | -111.03M | -9.76M | -2.9M |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 |
| Minority Interest | 1.87M | 0 | 0 | 0 |
Quick answers to the most common questions about buying MEDS stock.
As of 2025, DataMEDS AI, Inc. (MEDS) had total assets of $30.5M including $2.8M in current assets.
DataMEDS AI, Inc. (MEDS) carries total debt of $24.8M, offset by $0.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
DataMEDS AI, Inc. (MEDS) has total shareholders' equity (book value) of $-12.4M ($-8.77 book value per share). Book value represents the net worth of the company belonging to common stock holders.
DataMEDS AI, Inc. (MEDS) reported a current ratio of 0.09x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Negative equity and persistent cash burn
Metrics are mathematically derived from official filings.
Equity Deficit Deepens Despite Asset Growth
Based on reported figures, DataMEDS AI moved from $10.0M of equity in 2024Q3 to a deficit of -$1.7M in 2026Q3, while accumulated deficit widened from -$5.4M to -$126.5M over the same period.
The erosion of equity is driven by the accumulated deficit rather than by any single discrete event, which suggests losses have consistently outpaced capital retained in the business. Total assets rose to $38.7M in 2026Q3 from $30.1M in 2026Q1, but liabilities grew at a similar pace, so the balance sheet expansion appears to be financed by obligations rather than by owner capital. Investors should monitor whether the balance sheet stabilizes or continues to weaken, since a negative equity position limits the company's cushion against further losses.
Leverage Rises as Equity Turns Negative
According to the reported statements, total debt of $19.9M in 2026Q3 against a negative equity base produces a D/E ratio of 116.15, a figure that reflects the depleted equity cushion rather than a modest debt load.
Debt declined from $32.6M in 2026Q2 to $19.9M in 2026Q3, which may indicate partial repayment or reclassification, though the reported figures do not disclose the mechanism. The D/E ratio is extreme in part because it is computed against near-zero equity, so it overstates leverage in a relative sense while still signaling that creditors hold a dominant claim on the asset base. Refinancing terms and maturity schedules are not provided in the supplied data, so the ability to service this debt warrants further investigation.
Asset Base Dominated by Non-Productive Holdings
Based on EDBL-style reported figures, goodwill of $15.8M and net PPE of $1.9M in 2026Q3 together account for roughly 45% of total assets of $38.7M, pointing to an asset base weighted toward intangibles.
The business appears asset-light in physical terms, with PPE declining from $2.1M in 2024Q2 to $1.9M in 2026Q3, which suggests limited reinvestment in productive capacity. Goodwill has held near $14 to $16M across the period, so its recoverability is a material judgment, and an impairment would further reduce an already negative equity balance. The composition suggests that reported asset values may depend heavily on acquisition accounting rather than on tangible earning power.
Thin Liquidity Buffer Against Obligations
As reported in financial statements, cash of $476.6K against a current ratio of 0.14 in 2026Q3 indicates that current liabilities are many multiples of available liquid resources.
A current ratio of 0.14 means the company holds roughly $0.14 of current assets for each dollar of current obligations, a position that is structurally fragile regardless of the underlying business outlook. Cash has fluctuated between roughly $42K and $4.2M across the ten quarters, offering little durable buffer against operating shortfalls. The data does not disclose committed credit facilities, so any external funding access is unverified and should not be assumed.
Headline Assets Mask Negative Net Worth
Based on reported figures, total assets of $38.7M in 2026Q3 appear substantial in isolation, yet they are fully offset by liabilities of $38.6M, leaving equity negative and the asset base largely committed to creditors.
The most misleading read would be to treat the $38.7M asset total as evidence of scale or stability, since the entire asset base is matched by claims that exceed it in aggregate. Goodwill and other intangibles of roughly $15.8M carry impairment risk that, if recognized, would deepen the equity deficit without any change in cash. This analysis is inferential from the reported figures and does not account for contingent liabilities, lease obligations, or other items not disclosed in the supplied data.